Human challenge trials come of age as hVIVO lands world-first whooping cough contract Proactive Investors (UK) 16:20 Wed, 22 Apr
hVIVO shares rise 7% as Cavendish hails "landmark" whooping cough trial contract Proactive Investors (UK) 08:53 Wed, 22 Apr
hVIVO to conduct world's first pivotal phase III whooping cough human challenge trial Proactive Investors (UK) 07:32 Wed, 22 Apr
hVIVO full-year results: Growth strategy and outlook - ICYMI Proactive Investors (UK) 05:53 Sat, 18 Apr
Cavendish sees hVIVO's transition year setting platform for recovery as CRO market conditions stabilise Proactive Investors (UK) 16:30 Wed, 15 Apr
hVIVO targets strong return to growth after transition year Proactive Investors (UK) 07:50 Wed, 15 Apr
Cavendish maintains buy on hVIVO after influenza trial contract win, sees revenues weighted to 2026 Proactive Investors (UK) 15:24 Tue, 14 Apr
hVIVO shares rise 11% as influenza trial win and rebrand signal integrated strategy bearing fruit Proactive Investors (UK) 08:57 Tue, 14 Apr
hVIVO inks influenza trial contract and unveils unified brand as integrated platform strategy takes shape Proactive Investors (UK) 07:56 Tue, 14 Apr
